Citadel Advisors - TAYSHA GENE THERAPIES INC ownership

TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 72 filers reported holding TAYSHA GENE THERAPIES INC in Q1 2022. The put-call ratio across all filers is 1.51 and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of TAYSHA GENE THERAPIES INC
ValueSharesWeighting
Q3 2023$196,552
+2040.2%
62,200
+347.7%
0.00%
Q2 2023$9,184
-19.4%
13,893
-2.8%
0.00%
Q1 2023$11,400
-98.0%
14,293
-94.4%
0.00%
Q4 2022$573,387
+124.0%
253,711
+90.8%
0.00%
Q3 2022$256,000
-48.5%
132,980
-0.5%
0.00%
Q2 2022$497,000
-66.2%
133,591
-40.7%
0.00%
Q1 2022$1,469,000
+247.3%
225,349
+520.2%
0.00%
Q4 2021$423,000
-55.4%
36,337
+1.6%
0.00%
Q4 2020$949,000
-82.7%
35,752
-85.4%
0.00%
-100.0%
Q3 2020$5,489,000245,0340.00%
Other shareholders
TAYSHA GENE THERAPIES INC shareholders Q1 2022
NameSharesValueWeighting ↓
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGMENT CO 1,147,040$13,363,0006.07%
Sands Capital Ventures, LLC 724,873$8,445,0001.25%
Quantum Private Wealth, LLC 145,718$1,697,0000.64%
Nantahala Capital Management 1,456,147$16,964,0000.60%
Artal Group S.A. 1,040,882$12,126,0000.33%
Alphabet Inc. 640,882$7,466,0000.18%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 500,000$5,825,0000.17%
TimesSquare Capital Management, LLC 659,100$7,679,0000.07%
GSA CAPITAL PARTNERS LLP 40,885$476,0000.06%
Virtus ETF Advisers LLC 11,519$134,0000.05%
View complete list of TAYSHA GENE THERAPIES INC shareholders